Equites Radar

STE · STERIS plc (Ireland)

Medical DevicesUnited StatesAnalyst view: none

$210.76

-0.80% last session

End-of-day data · close of 2026-09-11

Bearish1 bullish · 5 bearish technical signals
To mean target: +23.9%

Market cap

$21B

Enterprise value

$22B

Trailing P/E

26.0

Forward P/E

17.4

Dividend yield

1.0%

Beta

0.91

Avg volume

1M

Employees

18K

Daily Change %

-0.80%

5 Days Change

-4.23%

10 Days Change

-7.26%

30 Days Change

-9.44%

60 Days Change

-0.12%

Month to Day Change

-6.05%

Year to Day Change

-14.43%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts8
Mean price target$263.12
Low price target$232.00
Upside to mean target+23.9%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)27.1
50-day MA$224.80
200-day MA$230.67
Price vs 50-day MA-6.3%
Price vs 200-day MA-8.6%
MACD histogram-3.06
Volume vs 3-month avg0.8×
52w low $198.7952w high $266.36

Analyst sentiment over time — STE

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-08-07

Latest call per bank · past 12 months

UBS

Buy

$270

+27.1% vs price
▼ cut from $275Maintains · 2026-08-07

Recent rating actions

DateFirmActionRatingPrice target
2026-08-07UBSMaintainsBuy$275 $270
2026-08-07Piper SandlerReiteratesOverweight$270 $275
2026-07-28UBSInitiatesBuy$0.00 $275
2026-05-13KeybancMaintainsOverweight$291 $269

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 27 — oversold territory; selling pressure looks stretched.
  • Price vs 50-day MA: Trading 6.2% below the 50-day MA ($224.80).
  • Price vs 200-day MA: Trading 8.6% below the 200-day MA ($230.67).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-3.06) — short-term momentum is fading.
  • 52-week range: Price is within 10% of the 52-week low ($198.79).

STE Price Chart

Loading chart for STE

Fundamentals

Revenue (TTM)$6.0B
EBITDA$2.0B
Free cash flow$1.0B
Operating cash flow$1.0B
Book value / share$73.92
Net Debt / EBITDA1.0
WACC10.0%
Revenue growth7.00%
Earnings growth14.00%

About STERIS plc (Ireland)

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

More in Medical Devices

Screen STE against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.